Cardiotoxicity in Patients With Lung Cancer Receiving Thoracic Radiotherapy and Immune-Checkpoint Therapy

被引：0
|
作者：
Son, C. [1 ]
Moey, M. [2 ]
Naqash, A. [3 ]
Walker, P. [4 ]
Peach, M. S. [5 ]
Ju, A. W. [5 ]
机构：
[1] East Carolina Univ, Brody Sch Med, Greenville, NC 27858 USA
[2] East Carolina Univ, Dept Cardiovasc Sci, Brody Sch Med, Greenville, NC 27858 USA
[3] East Carolina Univ, Brody Sch Med, Dept Hematol Oncol, Greenville, NC 27858 USA
[4] NCI, Affiliat Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[5] East Carolina Univ, Brody Sch Med, Dept Radiat Oncol, Greenville, NC 27858 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2467
引用
收藏
页码：E235 / E236
页数：2
相关论文
共 50 条
  • [41] The impact of cancer pain on survival of lung cancer patients receiving immune checkpoint inhibitors
    Wang, S.
    Ye, Z-H.
    Zhang, J.
    Lee, T. T. L.
    Wai, A. K. C.
    Kong, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S890 - S890
  • [42] Impact of radiotherapy schedule on survival of patients treated with immune-checkpoint inhibitors for advanced melanoma and non-small cell lung cancer
    Sumodhee, S.
    Guo, L.
    Bouhlel, L.
    Picard, A.
    Otto, J.
    Naghavi, A. O.
    Richier, Q.
    Levy, A.
    Bondiau, P-Y
    Poudenx, M.
    Passeron, T.
    Lacour, J-P
    Montaudie, H.
    Doyen, J.
    CANCER RADIOTHERAPIE, 2022, 26 (08): : 1045 - 1053
  • [43] Tumor mutation burden in the prognosis and response of lung cancer patients to immune-checkpoint inhibition therapies
    Vryza, Paraskevi
    Fischer, Timo
    Mistakidi, Elena
    Zaravinos, Apostolos
    TRANSLATIONAL ONCOLOGY, 2023, 38
  • [44] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, Kohei
    Yamamoto, Yuki
    Kanai, Osamu
    Okamura, Misato
    Hashimoto, Masayuki
    Nakatani, Koichi
    Sawai, Satoru
    Mio, Tadashi
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (05):
  • [45] Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Fujita, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [46] TRANSCRIPTOMIC CHANGES IN CANCER PATIENTS TREATED WITH IMMUNE-CHECKPOINT INHIBITORS
    Shek, Dmitrii
    Gao, Bo
    Lai, Joey
    Yoon, Won-Hee
    Moujaber, Tania
    Nagrial, Adnan
    Carlino, Matteo
    Read, Scott
    Ahlenstiel, Golo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A552 - A552
  • [47] Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease
    Suzuki, Kunihiro
    Yanagihara, Toyoshi
    Matsumoto, Koichiro
    Kusaba, Hitoshi
    Yamauchi, Takuji
    Ikematsu, Yuki
    Tanaka, Kentaro
    Otsubo, Kohei
    Inoue, Hiroyuki
    Yoneshima, Yasuto
    Iwama, Eiji
    Arimura-Omori, Masako
    Harada, Eiji
    Hamada, Naoki
    Okamoto, Isamu
    Nakanishi, Yoichi
    INTERNATIONAL IMMUNOLOGY, 2020, 32 (08) : 547 - 557
  • [48] CLOSTRIDIOIDES DIFFICILE INFECTIONS IN CANCER PATIENTS ON IMMUNE-CHECKPOINT INHIBITORS
    Vasavada, Shaleen
    Amin, Rajan
    Okhuysen, Pablo C.
    Thomas, Anusha Shirwaikar
    Wang, Yinghong
    GASTROENTEROLOGY, 2021, 160 (06) : S50 - S51
  • [49] Early evaluation of subclinical cardiotoxicity in patients with lung cancer receiving immune checkpoint inhibitors by cardiovascular magnetic resonance: a prospective observational study
    Liu, Jia
    Cao, Yukun
    Zhu, Kuikui
    Yao, Sheng
    Yuan, Mei
    Kong, Xiangchuang
    Liu, Xiaoming
    Li, Yumin
    Cui, Yue
    Han, Xiaoyu
    Zhou, Xiaoyue
    Meng, Rui
    Shi, Heshui
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (10) : 4771 - 4785
  • [50] Synergistic Strategies for Lung Cancer Immunotherapy: Combining Phytochemicals and Immune-Checkpoint Inhibitors
    Gao, Quan
    Wu, Hao
    Li, Zhengjun
    Yang, Zijing
    Li, Lin
    Sun, Xueni
    Wu, Qibiao
    Sui, Xinbing
    PHYTOTHERAPY RESEARCH, 2025,
12345